Schwartz Investment Counsel Inc. Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE)

Schwartz Investment Counsel Inc. decreased its holdings in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 25.2% during the third quarter, HoldingsChannel reports. The institutional investor owned 119,000 shares of the medical instruments supplier’s stock after selling 40,000 shares during the period. Schwartz Investment Counsel Inc.’s holdings in Haemonetics were worth $10,660,000 at the […]

Leave a Reply

Your email address will not be published.

Previous post Rheos Capital Works Inc. Has $19.21 Million Stock Position in SentinelOne, Inc. (NYSE:S)
Next post Summit Financial Group Inc. Reduces Stock Position in iShares MSCI ACWI ETF (NASDAQ:ACWI)